Corventis Announces Enrollment Completion of Clinical Trial Studying Non-Invasive Multi-Sensor Monitoring for Congestive Heart Failure
9/14/2009 10:00:54 AM
BOSTON & SAN JOSE, Calif.--(BUSINESS WIRE)--Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced today enrollment completion of the company’s MUSIC (Multi-Sensor Monitoring in Congestive Heart Failure) program consisting of 2 trials: the MUSIC Asia (180 patients) and the pivotal MUSIC study (362 patients). The MUSIC program – the goal of which is to develop and evaluate an algorithm to predict heart failure events – has enrolled a total of 542 patients in the international, multi-center prospective trials. Preliminary findings from the MUSIC Asia study were presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston, Mass.
comments powered by